A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. The findings will be presented by ...
The samples are from patients across the country living with breastcancer. Knutson and his team work long hours in the cancervaccine research lab, looking for answers to the same questions ...